CN1381256A - Composite Chinese medicine for treating prostatitis - Google Patents
Composite Chinese medicine for treating prostatitis Download PDFInfo
- Publication number
- CN1381256A CN1381256A CN 02114100 CN02114100A CN1381256A CN 1381256 A CN1381256 A CN 1381256A CN 02114100 CN02114100 CN 02114100 CN 02114100 A CN02114100 A CN 02114100A CN 1381256 A CN1381256 A CN 1381256A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- poria
- treatment
- salviae miltiorrhizae
- rhizoma dioscoreae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating prostatitis is prepared from 7 Chinese medicinal materials including trichosanthes root, tuckahoe, yam, red sage root, vaccaria seed, etc.. It has more than 95% for total effective rate and more than 70% for cure rate.
Description
Affiliated technical field: the present invention relates to a kind of Chinese medicine composition, the prostatitic Chinese medicine composition of particularly a kind of treatment.
Background technology: the Chinese medicinal formulae of gland is few before the existing treatment, effect differs, particularly not satisfactory to the therapeutic effect and the cure rate of prostatitis pertinacious disease, as return elm China fir agent prescription to be: Radix Angelicae Sinensis 25g, Cortex ulmi pumilae 15g, Santalum album 15g, Cortex Phellodendri (processed with wine) 15g, Sichuan Cordyceps 15g, newborn Poria 15g, hundred knotweed 15g, succinum 8g, water are fried in shallow oil branch for two bowls, and slag is with decoction potion on the one.
Summary of the invention: the invention provides a kind of pure Chinese medicinal preparation of prostatitic Chinese medicine composition for being made up of radices trichosanthis, Poria, Rhizoma Dioscoreae, Herba Dianthi, Radix Salviae Miltiorrhizae, Semen Vaccariae, Radix Glycyrrhizae seven flavor Chinese medicines for the treatment of, its weight percentages of components scope is: radices trichosanthis 13-20, Poria 10-15, Rhizoma Dioscoreae 18-22, Herba Dianthi 10-15, Radix Salviae Miltiorrhizae 13-20, Semen Vaccariae 13-20, Radix Glycyrrhizae 2-5.This compositions can be made as decoction, concentrate decoction, powder and capsule or pill or tabletting.
Beneficial effect of the present invention is through routine clinical diagnosis and treatment surplus in the of 300 closely for many years, and its effective percentage is that cure rate reaches more than 70% more than 95%.
Embodiment: the invention will be further described below in conjunction with embodiment:
Weight percentages of components scope of the present invention is: radices trichosanthis 13-20%, Poria 10-15%, Rhizoma Dioscoreae 10-22%, Herba Dianthi 10-15%, Radix Salviae Miltiorrhizae 13-20%, Semen Vaccariae 13-20%, Radix Glycyrrhizae 2-5% total amount are 100%.Its most preferred embodiment prescription proportioning is that radices trichosanthis 17.0%, Poria 13.0%, Rhizoma Dioscoreae 20.0%, Herba Dianthi 13.0%, Radix Salviae Miltiorrhizae 17.0%, Semen Vaccariae 17.0%, Radix Glycyrrhizae 3.0%, its total amount are 100%, can be made into Chinese patent medicines such as decoction, powder, capsule or pill, also can purchase medicine from frying in shallow oil from pharmacy by prescription, day is taken potion, and 10 doses is a course of treatment.Can heal 2-3 the course of treatment.It fries in shallow oil the prescription consumption is radices trichosanthis 15g, Poria 12g, Rhizoma Dioscoreae 18g, Herba Dianthi 12g, Radix Salviae Miltiorrhizae 15g, Semen Vaccariae 15g, Radix Glycyrrhizae 3g.
Claims (3)
1, the prostatitic Chinese medicine composition of a kind of treatment is made up of radices trichosanthis, Poria, Rhizoma Dioscoreae, Herba Dianthi, Radix Salviae Miltiorrhizae, Semen Vaccariae, Radix Glycyrrhizae seven flavor Chinese medicines, it is characterized in that its each weight percentages of components scope is: radices trichosanthis 13-20%, Poria 10-15%, Rhizoma Dioscoreae 18-22%, Herba Dianthi 10-15%, Radix Salviae Miltiorrhizae 13-20%, Semen Vaccariae 13-20%, Radix Glycyrrhizae 2-5%, its total amount is 100%.
2, the prostatitic Chinese medicine composition of a kind of treatment as claimed in claim 1 is characterized in that best proportioning is: radices trichosanthis 17%, Poria 13%, Rhizoma Dioscoreae 20%, Herba Dianthi 13%, Radix Salviae Miltiorrhizae 17%, Semen Vaccariae 17%, Radix Glycyrrhizae 3.0%.
3, as the prostatitic Chinese medicine composition of a kind of treatment of claim 1 or 2, it is characterized in that its dosage form is a decoction, or powder, or tabletting, or capsule, or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021141002A CN1166390C (en) | 2002-04-23 | 2002-04-23 | Composite Chinese medicine for treating prostatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021141002A CN1166390C (en) | 2002-04-23 | 2002-04-23 | Composite Chinese medicine for treating prostatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1381256A true CN1381256A (en) | 2002-11-27 |
| CN1166390C CN1166390C (en) | 2004-09-15 |
Family
ID=4742950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021141002A Expired - Fee Related CN1166390C (en) | 2002-04-23 | 2002-04-23 | Composite Chinese medicine for treating prostatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1166390C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108452142A (en) * | 2018-04-26 | 2018-08-28 | 刘学康 | A kind of Chinese medicine composition, application, preparation method, preparation |
-
2002
- 2002-04-23 CN CNB021141002A patent/CN1166390C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108452142A (en) * | 2018-04-26 | 2018-08-28 | 刘学康 | A kind of Chinese medicine composition, application, preparation method, preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1166390C (en) | 2004-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1907404A (en) | Medicine for treating mental disorder | |
| CN1475229A (en) | Antifatigue compound Chinese medicine prescription and its preparation method | |
| CN101297889B (en) | Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof | |
| CN1919296A (en) | Decoction medicine for treating recrudescent stomatocace and its preparation method | |
| CN1055837C (en) | Preparation of brain-care pill | |
| CN102210719A (en) | Manufacturing method of Chinese medical brick | |
| CN1137720C (en) | Chinese medicine for treating diabetes and its complication | |
| CN106492138A (en) | The Chinese medicine preparation for the treatment of insomnia | |
| CN1046421C (en) | Drug for curing pulmonary tuberculosis | |
| CN103285329B (en) | Medicament for treating women dysmenorrhea and preparation method thereof | |
| CN105963467A (en) | Traditional Chinese medicine composition, application thereof and preparation | |
| CN100406046C (en) | Medicine for treating oral lichen planus | |
| CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN101757444A (en) | Orally administrated medicine for Chinese traditional treatment of thyroid nodule | |
| CN1166390C (en) | Composite Chinese medicine for treating prostatitis | |
| CN103721187A (en) | Blood-circulation-promoting and blood-fat-reducing pill for treating hyperlipemia and preparation method of pill | |
| CN1063960C (en) | Chinese medicine for treating hepatitis B | |
| CN1297310C (en) | Medicated liquor for curing chronic gastritis and gastric ulcer | |
| CN105368672A (en) | Health-care wine containing phellinus | |
| KR20010000070A (en) | Agents for diabetes and the manufacturing method thereof | |
| CN1559496A (en) | Chinese medicine preparation of removing obstruction in the channels for treating atrophic arthritis | |
| CN1363386A (en) | Composition Chinese-medicinal herb pieces and preparing process thereof | |
| CN100333764C (en) | Pill for treating liver disease | |
| CN1634471A (en) | Chinese traditional medicine for treating cardiopathy | |
| CN1857619A (en) | Chinese medicine preparation for curing diabetes radically |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040915 |